The University of California, San Francisco Cancer of the Prostate Risk Assessment score: A straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy

Journal of Urology

Volumn 173, Issue 6, 2005, Pages 1938-1942

  Cooperberg, Matthew R ^d   Pasta, David J ^d   Elkin, Eric P ^d   Litwin, Mark S ^a   Latini, David M ^d   Duchane, Janeen ^d   Carroll, Peter R ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TAP PHARMACEUTICAL PRODUCTS INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE

Author keywords

Prognosis; Prostate specific antigen; Prostatic neoplasms; Risk factors

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; FOLLOW UP; GLEASON SCORE; HAZARD ASSESSMENT; HUMAN; HUMAN TISSUE; INSTRUMENT; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RELIABILITY; RISK ASSESSMENT; SCORING SYSTEM; UNIVERSITY OF CALIFORNIA SAN FRANCISCO CANCER OF THE PROSTATE RISK ASSESSMENT SCORE; VALIDATION PROCESS;

EID: 18744371597     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000158155.33890.e7     Document Type: Article

References (20)

1. Jemal, A., Tiwari, R. C., Murray, T., Ghafoor, A., Samels, A., Ward, E. et al: Cancer statistics, 2004. CA Cancer J Clin, 54: 8, 2004
2. Albertsen, P. C., Hanley, J. A., Gleason, D. F. and Barry, M. J.: Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA, 280: 975, 1998
3. Holmberg, L., Bill-Axelson, A., Helgesen, F., Salo, J. O., Folmerz, P., Haggman, M. et al: A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med, 347: 781, 2002
4. Wei, J. T., Dunn, R. L., Sandler, H. M., McLaughlin, P. W., Montie, J. E., Litwin, M. S. et al: Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol, 20: 557, 2002
5. Ross, P. L., Scardino, P. T. and Kattan, M. W.: A catalog of prostate cancer nomograms. J Urol, 165: 1562, 2001
6. D'Amico, A. V., Whittington, R., Malkowicz, S. B., Schultz, D., Blank, K., Broderick, G. A. et al: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA, 280: 969, 1998
7. Kattan, M. W., Eastham, J. A., Stapleton, A. M., Wheeler, T. M. and Scardino, P. T.: A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst, 90: 766, 1998
8. Lubeck, D. P., Litwin, M. S., Henning, J. M., Stier, D. M., Mazonson, P., Fisk, R. et al: The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology, 48: 773, 1996
9. Cooperberg, M. R., Broering, J. M., Litwin, M. S., Lubeck, D. P., Mehta, S. S., Henning, J. M. et al: The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CaPSURE), a national disease registry. J Urol, 171: 1393, 2004
10. Mitchell, J. A., Cooperberg, M. R., Elkin, E. P., Lubeck, D. P., Mehta, S. S., Kane, C. J. et al: Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE. J Urol, 173: 1126, 2005
11. Partin, A. W., Mangold, L. A., Lamm, D. M., Walsh, P. C., Epstein, J. I. and Pearson, J. D.: Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology, 58: 843, 2001
12. Greene, K. L., Meng, M. V., Elkin, E. P., Cooperberg, M. R., Pasta, D. J., Kattan, M. W. et al: Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE). J Urol, 171: 2255, 2004
13. Smith, C. V., Bauer, J. J., Connelly, R. R., Seay, T., Kane, C., Foley, J. et al: Prostate cancer in men age 50 years or younger: a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database. J Urol, 164: 1964, 2000
14. Khan, M. A., Han, M., Partin, A. W., Epstein, J. I. and Walsh, P. C.: Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003. Urology, 62: 86, 2003
15. Presti, J. C., Jr., Shinohara, K., Bacchetti, P., Tigrani, V. and Bhargava, V.: Positive fraction of systematic biopsies predicts risk of relapse after radical prostatectomy. Urology, 52: 1079, 1998
16. D'Amico, A. V., Whittington, R., Malkowicz, S. B., Schultz, D., Fondurulia, J., Chen, M. H. et al: Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer. J Clin Oncol, 18: 1164, 2000
17. Freedland, S. J., Csathy, G. S., Dorey, F. and Aronson, W. J.: Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score. J Urol, 167: 516, 2002
18. Grossfeld, G. D., Latini, D. M., Lubeck, D. P., Broering, J. M., Li, Y. P., Mehta, S. S. et al: Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE. Urology, 59: 560, 2002
19. Graefen, M., Ohori, M., Karakiewicz, P. I., Cagiannos, I., Hammerer, P. G., Haese, A. et al: Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer. J Urol, 171: 200, 2004
20. Freedland, S. J., Aronson, W. J., Csathy, G. S., Kane, C. J., Amling, C. L., Presti, J. C., Jr. et al: Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database. Urology, 61: 742, 2003